Tom Almey
Geschäftsführer bei Ziphius Vaccines NV
Profil
Tom Almey is currently the Chief Operating Officer at Ziphius Vaccines NV.
Previously, he worked as the COO, Director & Head-Regulatory at Ecuphar NV and as the Head-Operations at Mooss Pharma.
He obtained his undergraduate degree from Ghent University in 1994.
Aktive Positionen von Tom Almey
| Unternehmen | Position | Beginn |
|---|---|---|
Ziphius Vaccines NV
 Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then. | Geschäftsführer | 01.01.2019 |
Ehemalige bekannte Positionen von Tom Almey
| Unternehmen | Position | Ende |
|---|---|---|
Mooss Pharma
 Mooss Pharma Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Mooss Pharma is a Belgian company that manufactures and distributes pharmaceutical preparations. The company is located in Belgium. The company was founded by Christian Cardon. Mooss Pharma was acquired by Omega Pharma NV, part of Perrigo Co. Plc from March 30, 2015 on August 07, 2001 for $10.56 million. | Geschäftsführer | - |
Ecuphar NV
 Ecuphar NV Agricultural Commodities/MillingProcess Industries Ecuphar NV develops and markets veterinary products and services. It offers healthcare products and services for veterinarians and animal owners. The firm offers products for companion animals, large animals, and horses. The company was founded by Christian Cardon in 2003 and is headquartered in Oostkamp, Belgium. | Geschäftsführer | - |
Ausbildung von Tom Almey
| Ghent University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Ecuphar NV
Ecuphar NV Agricultural Commodities/MillingProcess Industries Ecuphar NV develops and markets veterinary products and services. It offers healthcare products and services for veterinarians and animal owners. The firm offers products for companion animals, large animals, and horses. The company was founded by Christian Cardon in 2003 and is headquartered in Oostkamp, Belgium. | Process Industries |
Mooss Pharma
Mooss Pharma Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Mooss Pharma is a Belgian company that manufactures and distributes pharmaceutical preparations. The company is located in Belgium. The company was founded by Christian Cardon. Mooss Pharma was acquired by Omega Pharma NV, part of Perrigo Co. Plc from March 30, 2015 on August 07, 2001 for $10.56 million. | Health Technology |
Ziphius Vaccines NV
Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then. | Health Technology |
